"C radiotracer studies have been used to identify five compounds as aflatoxin precursors. These intermediates are norsolorinic acid (12) , averufin (17, 18) , versiconal hemiacetal acetate (3, 8, 24) , versicolorin A (14) , and sterigmatocystin (11) . The structures of these compounds and of aflatoxin B1 are presented in Fig. 1 . Norsolorinic acid, averufin, versiconal hemiacetal acetate, and versicolorin A are substituted polyhydroxyanthraquinones; sterigmatocystin is a xanthone. Norsolorinic acid (4, 16) , averufin (6) , and versicolorin A (15) are accumulated by blocked mutants of A. parasiticus. Versiconal hemiacetal acetate accumulates during dichlorvos treatment of aflatoxigenic strains of A. parasiticus (8, 24) . Sterigmatocystin, which shows the highest incorporation of 14C label into aflatoxin B1 of the known precursors, is a natural metabolite of A. versicolor (9, 13) and a number of other fungal species (21) . There is one published report of sterigmatocystin from an aflatoxigenic species (22) .
We have isolated a new mutant strain of A.
parasiticus that is blocked in aflatoxin production and that accumulates a number of polyhydroxyanthraquinones. We nals of the methine carbon tend to be in exchange with the two hydroxyls in the adjacent rings, giving rise to a lower proton integration.
The structure of averantin is shown in Fig. 1  (II) , along with the structures ofthe other known precursors of aflatoxin B1. The thin-layer chromatographic mobility of averantin was compared with the mobility of norsolorinic acid (Fig.  1, I ), averufin (Fig. 1, III) , versicolorin A (Fig. 1,  V) and versiconal hemiacetal acetate (Fig. 1, IV Table 3 . Averantin showed an incorporation efficiency of 15.3%, and acetate showed an incorporation efficiency of 0.72%. Also presented in Table 3 are the specific activities of the precursors and the product (aflatoxin B1) and the relative specific activities. Specific activity is a measure of the amount of radioactivity in a compound. The specific activities of the precursors were different, because the sodium 800 400 acetate was not diluted with unlabeled carrier and had a high specific activity (58.5 ACi/mol), whereas the specific activity of the randomly labeled averantin was low (0.243 ,uCi/mol). However, the specific activity of the product formed from the two sources did not show such a wide difference. The specific activity of the aflatoxin B1 formed from [14C]averantin was 0.061, and the specific activity of the aflatoxin B1 formed with [1-14C] Table 4 ). Experiments that demonstrate the transformation of label from ['4C]averantin into averufin but not into norsolorinic acid, and the transformation of [l4C]norsolorinic acid into averantin, place averantin early in the aflatoxin pathway. On the basis of these results and previous studies (11, 12, 14, 17, 23, 24) , we add a new step to the biosynthetic pathway to aflatoxin B1 in which the general sequence is acetate --hypothetical polyketide intermediate --norsolorinic acid (Fig. 1, I ) --averantin (Fig. 1, II) --averufin (Fig. 1, III) -versiconal hemiacetal acetate (Fig. 1, IV) versicolorin A (Fig. 1, V ) -* sterigmatocystin ( Fig. 1, VI ) -* aflatoxin B1 (Fig.  1, VII) .
DISCUSSION

